eosine yellowish-(ys) has been researched along with Esophageal Neoplasms in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 4 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fu, J; Lin, G; Ling, Y; Liu, C; Pan, C; Wang, G; Wei, X; Wen, J; Weng, Z; Xie, X; Yang, H; Zhang, H; Zhong, J | 1 |
McDonald, OG; Montgomery, EA | 1 |
Chen, G; Chen, M; Chen, Y; Fang, W; Kang, Z; Li, J; Li, S; Wang, J; Wu, Z; Yao, Q; Zhang, H; Zhang, X; Zheng, F; Zheng, J | 1 |
Fujishiro, M; Funasaka, K; Furukawa, K; Hirooka, Y; Hosono, I; Ishikawa, T; Kawashima, H; Maeda, K; Miyahara, R; Nakamura, M; Ohno, E; Sawada, T; Tsukamoto, T; Yamamura, T; Yokoi, T | 1 |
Lam, AK | 2 |
Lam, AK; Saremi, N | 1 |
Becker, K; Feith, M; Karamitopoulou, E; Langer, R; Lordick, F; Ott, K; Slotta-Huspenina, J; Thies, S; Zlobec, I | 1 |
Feith, M; Guldener, L; Koelzer, VH; Kröll, D; Langer, R; Lugli, A; Seiler, CA; Slotta-Huspenina, J; Thies, S; Zlobec, I | 1 |
DeMeester, SR; Demeester, TR; Hagen, JA; Peters, JH; Taylor, CR; Waterman, TA | 1 |
Date, F; Goukon, Y; Itakura, Y; Nagura, H; Nishihira, T; Sasano, H | 1 |
Iwasaki, Y; Ozaki, A; Shibuya, S; Takase, Y | 1 |
12 other study(ies) available for eosine yellowish-(ys) and Esophageal Neoplasms
Article | Year |
---|---|
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
Topics: Eosine Yellowish-(YS); Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Prognosis; Tertiary Lymphoid Structures | 2022 |
Artificial intelligence for dysplasia grading in Barrett's esophagus: hematoxylin and eosin is here to stay.
Topics: Artificial Intelligence; Barrett Esophagus; Eosine Yellowish-(YS); Esophageal Neoplasms; Esophagoscopy; Hematoxylin; Humans; Precancerous Conditions | 2022 |
Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Topics: Biomarkers; Chemoradiotherapy; Eosine Yellowish-(YS); Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Hematoxylin; Humans; Lymphocytes, Tumor-Infiltrating; Prognosis; Retrospective Studies | 2023 |
Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Barrett Esophagus; Eosine Yellowish-(YS); Esophageal Neoplasms; Esophagectomy; Esophagus; Female; Hematoxylin; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mucous Membrane; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Platelet Endothelial Cell Adhesion Molecule-1; Retrospective Studies; Single-Blind Method; Staining and Labeling; Treatment Outcome | 2020 |
Histopathological Assessment for Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Biopsy; Eosine Yellowish-(YS); Esophageal Neoplasms; Esophagus; Hematoxylin; Humans; Lymph Nodes; Microscopy; Neoadjuvant Therapy; Neoplasm Grading; Staining and Labeling; Treatment Outcome | 2018 |
Application of Pathological Staging in Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Biopsy; Eosine Yellowish-(YS); Esophageal Neoplasms; Esophagectomy; Esophagus; Hematoxylin; Humans; Lymph Nodes; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Prognosis; Staining and Labeling; Treatment Outcome | 2018 |
Application of Tissue Microarray in Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Biopsy; Eosine Yellowish-(YS); Esophageal Neoplasms; Esophagectomy; Esophagus; Hematoxylin; Humans; Immunohistochemistry; Microtomy; Staining and Labeling; Tissue Array Analysis | 2018 |
Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Coloring Agents; Eosine Yellowish-(YS); Esophageal Neoplasms; Hematoxylin; Humans; Kaplan-Meier Estimate; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm, Residual; Observer Variation; Predictive Value of Tests; Remission Induction; Reproducibility of Results; Staining and Labeling; Treatment Outcome | 2014 |
Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy; Chi-Square Distribution; Coloring Agents; Eosine Yellowish-(YS); Esophageal Neoplasms; Germany; Hematoxylin; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Keratins; Logistic Models; Lymphatic Metastasis; Multivariate Analysis; Neoplasm Grading; Neoplasm Invasiveness; Observer Variation; Odds Ratio; Phenotype; Predictive Value of Tests; Proportional Hazards Models; Reproducibility of Results; Staining and Labeling; Switzerland | 2016 |
The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Chi-Square Distribution; Coloring Agents; Eosine Yellowish-(YS); Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Hematoxylin; Humans; Immunoenzyme Techniques; Keratins; Life Tables; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Prognosis; Single-Blind Method; Staining and Labeling; Survival Analysis | 2004 |
Confocal laser scanning microscopy in cytopathology.
Topics: Antigens, Neoplasm; Carcinoma, Squamous Cell; Eosine Yellowish-(YS); Esophageal Neoplasms; Humans; Immunohistochemistry; Lasers; Microscopy; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Propidium; Staining and Labeling; Tumor Suppressor Protein p53 | 1993 |
Fluorescence of metastasized lymph nodes in esophageal cancer following the administration of intravenous eosin yellow using a laser beam.
Topics: Aged; Carcinoma, Squamous Cell; Eosine Yellowish-(YS); Esophageal Neoplasms; Female; Fluorescence; Humans; Injections, Intravenous; Lasers; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged | 1988 |